Morpholino

MO1-crabp2b

ID
ZDB-MRPHLNO-120608-3
Name
MO1-crabp2b
Previous Names
None
Target
Sequence
5' - TGTTTTCTCCGTGTTAGATTCCATG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-crabp2b
Phenotype
Phenotype resulting from MO1-crabp2b
No data available
Phenotype of all Fish created by or utilizing MO1-crabp2b
Phenotype Fish Conditions Figures
rhombomere 7 poorly differentiated, abnormal WT + MO1-crabp2a + MO1-crabp2b chemical treatment: all-trans-retinoic acid Fig. 1 with image from Cai et al., 2012
hindbrain wholly posteriorized, abnormal WT + MO1-crabp2a + MO1-crabp2b chemical treatment: all-trans-retinoic acid Fig. 1 with image from Cai et al., 2012
hindbrain morphogenesis decreased process quality, abnormal WT + MO1-crabp2a + MO1-crabp2b standard conditions Fig. 1 with image from Cai et al., 2012
retinoic acid receptor signaling pathway decreased process quality, abnormal WT + MO1-crabp2a + MO1-crabp2b standard conditions Fig. 1 with image from Cai et al., 2012
rhombomere 7 poorly differentiated, abnormal WT + MO1-crabp2a + MO1-crabp2b standard conditions Fig. 1 with image from Cai et al., 2012
spinal cord neural tube poorly differentiated, abnormal WT + MO1-crabp2a + MO1-crabp2b chemical treatment: all-trans-retinoic acid Fig. 1 with image from Cai et al., 2012
spinal cord neural tube poorly differentiated, abnormal WT + MO1-crabp2a + MO1-crabp2b standard conditions Fig. 1 with image from Cai et al., 2012
hindbrain morphogenesis decreased process quality, abnormal WT + MO1-crabp2a + MO1-crabp2b chemical treatment: all-trans-retinoic acid Fig. 1 with image from Cai et al., 2012
retinoic acid receptor signaling pathway increased process quality, abnormal ld1Tg + MO1-crabp2a + MO1-crabp2b chemical treatment: all-trans-retinoic acid Fig. S6 with image from Cai et al., 2012
hindbrain morphogenesis decreased process quality, abnormal ld1Tg + MO1-crabp2a + MO1-crabp2b chemical treatment: all-trans-retinoic acid Fig. S6 with image from Cai et al., 2012
Citations